Life Sciences

Showing 501–506 of 506 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  MG (Myasthenia Gravis) Drug Market in China 2021

  The MG (myasthenia gravis) drug market in China in terms of revenue is set to grow by US$ 565 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 51% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the MG (myasthenia gravis) drug market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  ITP (Immune Thrombocytopenia) Drug Market in China 2021

  The ITP (immune thrombocytopenia) drug market in China in terms of revenue is set to grow by US$ 714 million during 2021-2027, growing at a compound annual growth rate (CAGR) of 25.3% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the ITP (immune thrombocytopenia) drug market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Therapeutic Antibody Market in China 2021

  The therapeutic antibody market in China in terms of revenue is set to grow by US$ 41 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 30.4% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the therapeutic antibody market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Online Retail Pharmacy Market in China 2021

  The online retail pharmacy market in China in terms of revenue is set to grow by US$ 146 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 33.3% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the online retail pharmacy market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Digital Health and Wellness Market in China 2021

  The digital health and wellness market in China in terms of revenue is set to grow by US$ 199 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 30.7% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the digital health and wellness market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450
• 

  Health and Wellness Market in China 2021

  The health and wellness market in China in terms of revenue is set to grow by US$ 1,044 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 9.4% during the forecast period, according to data and analytics company StrategyHelix. The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the health and wellness market to help drive informed decision making for industry executives, policy makers, academic, and analysts.

  USD 450